Why is ceruloplasmin measured in suspected Wilson disease?

Wilson disease impairs hepatic copper export, so ceruloplasmin — which normally carries copper — is characteristically low. However, because ceruloplasmin is not perfectly sensitive or specific, it must be interpreted with serum copper, urinary copper, slit-lamp examination, and genetic testing.

Can ceruloplasmin be normal in someone with Wilson disease?

Yes. Inflammation, pregnancy, or oestrogen therapy can raise ceruloplasmin into the normal range even in Wilson disease, and some patients have borderline-low rather than frankly low values. A normal result does not exclude the diagnosis if clinical suspicion persists.

What causes a low ceruloplasmin other than Wilson disease?

Copper deficiency, severe protein loss (nephrotic syndrome, protein-losing enteropathy), advanced liver failure, and the rare condition aceruloplasminaemia can all lower ceruloplasmin. Clinical context and concurrent tests help distinguish these.

What causes an elevated ceruloplasmin?

Inflammation, infection, malignancy, pregnancy, and oestrogen therapy all raise ceruloplasmin because it is an acute-phase protein. These elevations are non-specific and reflect the underlying condition rather than a copper disorder.

Is fasting required for a ceruloplasmin test?

No. Ceruloplasmin does not require fasting, though it is often drawn alongside serum copper and other tests that may specify fasting.

How is free copper calculated and why does it matter?

Free (non-ceruloplasmin-bound) copper is calculated from total serum copper and ceruloplasmin. In Wilson disease, free copper is elevated and toxic; this calculated fraction is more diagnostically useful than ceruloplasmin alone.

Should ceruloplasmin be measured in children differently?

Yes. Neonates and infants physiologically have lower ceruloplasmin, which rises during the first year. Paediatric reference ranges must be age-matched, and Wilson disease screening in very young children requires expert interpretation.

How long do ceruloplasmin results take?

Results are typically available within 2–4 business days from specimen receipt at the processing laboratory, though turnaround may vary slightly by routing lab.

BML-VIT-033vitamins mineralsUSA

Ceruloplasmin

Q: What is ceruloplasmin and what does it do?

Ceruloplasmin is a glycoprotein made in the liver that carries about 95 per cent of the copper in blood and also acts as a ferroxidase, helping convert iron for transport. It links copper and iron metabolism and rises as an acute-phase protein during inflammation.

The Ceruloplasmin test measures serum concentration of the principal copper-binding glycoprotein, ordered chiefly to screen for Wilson disease and evaluate copper status. Because ceruloplasmin is an acute-phase reactant elevated by inflammation and oestrogen, interpretation requires concurrent serum and urinary copper, clinical context, and often genetic confirmation.

Biomarkers

Blood (serum)

Sample

2–4 business days

Turnaround

Fasting

What is the Ceruloplasmin test?

The Ceruloplasmin test measures the serum concentration of the body's main copper-binding protein, ordered chiefly to investigate suspected Wilson disease and less commonly to evaluate copper status, unexplained neurological or psychiatric symptoms with liver involvement, or haemolytic anaemia of unclear cause. Because ceruloplasmin is an acute-phase reactant, its level rises in inflammation and falls in states of copper deficiency or impaired hepatic synthesis, making the result sensitive to a wide range of physiological and pathological influences that must be considered during interpretation. In the diagnostic pathway for Wilson disease — a life-altering but treatable condition — a low ceruloplasmin raises suspicion but is neither perfectly sensitive nor specific: roughly 95 per cent of symptomatic patients have reduced levels, yet 10–20 per cent of heterozygote carriers also show borderline-low values, and acute-phase elevation can bring a truly low value into the low-normal range. Practitioners therefore order ceruloplasmin as part of a multi-test panel that includes total and calculated free serum copper, 24-hour urinary copper, and often ophthalmological and genetic confirmation, rather than relying on ceruloplasmin alone.

What does the Ceruloplasmin test measure?

Cp(Ceruloplasmin)

Range: Approximately 20–60 mg/dL in adults; age- and assay-specific.Optimal: No single optimal range is defined; interpretation depends on clinical context, age, and whether inflammation or oestrogen is present. Persistent values <20 mg/dL warrant Wilson disease evaluation.mg/dL / g/L / µmol/L

Ceruloplasmin is an alpha-2-globulin glycoprotein synthesised in hepatocytes and functioning as the principal copper-carrying protein in serum, binding roughly 95 per cent of circulating copper. Beyond transport, it acts as a ferroxidase, catalysing oxidation of ferrous to ferric iron and enabling iron loading onto transferrin, thereby linking copper and iron metabolism. Ceruloplasmin is an acute-phase reactant, so its concentration rises during inflammation, infection, and oestrogen states (pregnancy, oral contraceptives). In health, hepatic copper incorporation into ceruloplasmin is tightly regulated, and most circulating copper is bound in this stable, functionally active form.

Serum ceruloplasmin is measured primarily to screen for and monitor Wilson disease, an autosomal-recessive disorder of hepatic copper export in which ceruloplasmin is characteristically low and unbound 'free' copper accumulates. Low ceruloplasmin also occurs in copper deficiency, severe protein loss (nephrotic syndrome, protein-losing enteropathy), and aceruloplasminaemia (a rare hereditary disorder of iron overload). Conversely, because ceruloplasmin is an acute-phase protein, it is elevated in inflammation, pregnancy, and oestrogen therapy, which can normalise values in Wilson disease and complicate interpretation. Ceruloplasmin should not be used in isolation to diagnose Wilson disease; it is one component of a diagnostic algorithm that includes serum copper, 24-hour urinary copper, slit-lamp examination for Kayser-Fleischer rings, and often genetic testing.

Why is the Ceruloplasmin test ordered?

Screening and diagnostic work-up of suspected Wilson disease in patients presenting with unexplained liver disease, neurological symptoms (tremor, dystonia, dysarthria), psychiatric manifestations, or haemolytic anaemia, particularly in children, adolescents, and young adults
Family screening of first-degree relatives of a confirmed Wilson disease proband, interpreted alongside genetic testing
Evaluation of copper deficiency in patients with unexplained anaemia, neutropenia, or myelopathy, especially following gastric surgery or chronic zinc supplementation
Investigation of persistent unexplained transaminase elevation or cirrhosis of unknown cause, where Wilson disease remains in the differential
Monitoring of known Wilson disease patients on chelation or zinc therapy, though 24-hour urinary copper is the primary metric for treatment adequacy
Assessment of suspected aceruloplasminaemia (a rare cause of iron overload with neurodegeneration) when ceruloplasmin is undetectable and iron studies are abnormal
Clarification of equivocal copper studies when serum total copper is borderline and the free copper fraction must be calculated

Sample collection and turnaround

Sample type

Blood (serum)

Fasting required

Collection method

Venipuncture at patient service centre

Turnaround

2–4 business days

Collection notes

Phlebotomy via LabCorp, Quest, Access Medical Laboratories, or DHA Laboratory draw site, depending on routing. No special preparation is required, though practitioners should be aware of acute illness, oestrogen use, and recent inflammation when interpreting. If Wilson disease is being evaluated, order serum copper and 24-hour urinary copper concurrently for a complete assessment. Avoid haemolysis, which can interfere with copper measurement.

Specimen requirements

Minimum 0.5 mL serum (gel separator acceptable). Ceruloplasmin is stable refrigerated for several days. Note the performing laboratory for serial comparability, as assay methods and reference ranges differ.

What can affect Ceruloplasmin results?

elevatesInflammation, infection, and acute-phase response

Ceruloplasmin is an acute-phase protein; inflammatory states, malignancy, and tissue injury raise hepatic synthesis, which can mask a truly low baseline and complicate Wilson disease screening.

elevatesOestrogen (pregnancy, oral contraceptives, hormone replacement)

Oestrogen stimulates ceruloplasmin production, often doubling or tripling levels during pregnancy; this can normalise a Wilson-disease-related low value and necessitate cautious interpretation or repeat testing off oestrogen.

reducesSevere protein loss (nephrotic syndrome, protein-losing enteropathy)

Non-specific loss of serum proteins lowers ceruloplasmin, which can mimic Wilson disease biochemically; urinary protein and albumin help distinguish.

reducesSevere hepatic synthetic dysfunction (advanced cirrhosis, fulminant hepatic failure)

When hepatocyte synthesis is critically impaired, ceruloplasmin falls along with albumin and clotting factors, so a low value in end-stage liver disease does not necessarily indicate Wilson disease.

reducesCopper deficiency

Inadequate dietary or absorbed copper limits hepatic incorporation into ceruloplasmin, producing a low serum level; seen with malabsorption, prolonged total parenteral nutrition without copper supplementation, or chronic high-dose zinc.

variableAge

Neonates and infants physiologically have lower ceruloplasmin, which rises during the first year of life; paediatric reference ranges must be age-matched, and Wilson disease screening in very young children requires expert interpretation.

What do Ceruloplasmin results mean?

Elevated

Inflammation, infection, malignancy, pregnancy, oestrogen therapy, and acute-phase states. An elevated ceruloplasmin does not exclude Wilson disease if the patient is acutely unwell or on oestrogen; repeat off confounders if suspicion is high.

Normal

A normal ceruloplasmin does not exclude Wilson disease, particularly in the presence of inflammation or oestrogen, or in paediatric patients whose reference ranges differ. If clinical suspicion persists, proceed with the full Wilson disease panel (serum copper, urinary copper, ophthalmological examination, genetic testing).

Reduced

Low ceruloplasmin (<20 mg/dL in most assays) suggests Wilson disease, copper deficiency, severe protein-losing states (nephrotic syndrome, enteropathy), aceruloplasminaemia, or advanced hepatic synthetic failure. In the Wilson disease work-up, low ceruloplasmin must be confirmed with low total serum copper, elevated calculated free (non-ceruloplasmin-bound) copper, elevated 24-hour urinary copper, Kayser-Fleischer rings on slit-lamp examination, and often ATP7B genetic testing. Heterozygote carriers of Wilson disease mutations may have borderline-low ceruloplasmin without disease.

Note: Ceruloplasmin is neither sensitive nor specific enough to diagnose Wilson disease on its own. Acute-phase elevation, oestrogen, and age all affect interpretation. Always measure ceruloplasmin alongside serum copper and calculate the free copper fraction; 24-hour urinary copper and genetic testing are often required for definitive diagnosis. Reference intervals vary by age, sex, and laboratory.

Frequently asked questions

Ceruloplasmin is a glycoprotein made in the liver that carries about 95 per cent of the copper in blood and also acts as a ferroxidase, helping convert iron for transport. It links copper and iron metabolism and rises as an acute-phase protein during inflammation.

How to access the Ceruloplasmin test

The Ceruloplasmin reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

European Association for Study of Liver. EASL clinical practice guidelines: Wilson disease. J Hepatol. (2012)
Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. (2008)
Members of the Working Party. Wilson disease: practical guidance from the British Association for Study of the Liver. Lancet Gastroenterol Hepatol. (2022)
Squitti R, et al. Ceruloplasmin/Transferrin ratio changes in Alzheimer's disease. Int J Alzheimers Dis. (2011)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.

Related tests

vitamins minerals

Zinc

The plasma zinc test measures circulating zinc, the most widely used marker of zinc status, to assess suspected deficiency and monitor repletion. It is insensitive to mild deficiency and falls non-specifically during inflammation and with low albumin, so it is interpreted alongside CRP, albumin, and the clinical picture.

BML-VIT-017View reference →

metabolic diabetes

CMP

The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.

BML-MET-003View reference →